In our study, we used BMI as a surrogate marker for obesity and found that EC patients with higher BMI were more likely to have lymph node metastasis, negative ER and PR expression, and deeper LVSI, which commonly predicts poor prognosis of EC. The gene discussed is ESR1; the disease is obesity disorder.